BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 37041492)

  • 1. Migraine symptoms, healthcare resources utilization and disease burden in a large Polish migraine cohort : Results from 'Migraine in Poland'-a nationwide cross-sectional survey.
    Waliszewska-Prosół M; Straburzyński M; Czapińska-Ciepiela EK; Nowaczewska M; Gryglas-Dworak A; Budrewicz S
    J Headache Pain; 2023 Apr; 24(1):40. PubMed ID: 37041492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences.
    Lipton RB; Munjal S; Alam A; Buse DC; Fanning KM; Reed ML; Schwedt TJ; Dodick DW
    Headache; 2018 Oct; 58(9):1408-1426. PubMed ID: 30341895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Migraine disability awareness campaign in Asia: migraine assessment for prophylaxis.
    Wang SJ; Chung CS; Chankrachang S; Ravishankar K; Merican JS; Salazar G; Siow C; Cheung RT; Phanthumchinda K; Sakai F
    Headache; 2008 Oct; 48(9):1356-65. PubMed ID: 19031500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The American Registry for Migraine Research: Research Methods and Baseline Data for an Initial Patient Cohort.
    Schwedt TJ; Digre K; Tepper SJ; Spare NM; Ailani J; Birlea M; Burish M; Mechtler L; Gottschalk C; Quinn AM; McGillicuddy L; Bance L; Dumkrieger G; Chong CD; Dodick DW
    Headache; 2020 Feb; 60(2):337-347. PubMed ID: 31755111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sinonasal symptoms in migraine without aura: results from the cross-sectional 'Migraine in Poland' study.
    Straburzynski M; Nowaczewska M; Czapinska-Ciepiela EK; Gryglas-Dworak A; Budrewicz S; Waliszewska-Prosół M
    Front Neurol; 2023; 14():1321261. PubMed ID: 38046593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burden of Illness Among People with Migraine and ≥ 4 Monthly Headache Days While Using Acute and/or Preventive Prescription Medications for Migraine.
    Buse DC; Yugrakh MS; Lee LK; Bell J; Cohen JM; Lipton RB
    J Manag Care Spec Pharm; 2020 Oct; 26(10):1334-1343. PubMed ID: 32678721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache-Related Disability.
    Lipton RB; Manack Adams A; Buse DC; Fanning KM; Reed ML
    Headache; 2016 Sep; 56(8):1280-9. PubMed ID: 27349336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Most Bothersome Symptom in Persons With Migraine: Results From the Migraine in America Symptoms and Treatment (MAST) Study.
    Munjal S; Singh P; Reed ML; Fanning K; Schwedt TJ; Dodick DW; Buse DC; Lipton RB
    Headache; 2020 Feb; 60(2):416-429. PubMed ID: 31837007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) Study.
    Buse DC; Loder EW; Gorman JA; Stewart WF; Reed ML; Fanning KM; Serrano D; Lipton RB
    Headache; 2013 Sep; 53(8):1278-99. PubMed ID: 23808666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study.
    Buse DC; Reed ML; Fanning KM; Bostic R; Dodick DW; Schwedt TJ; Munjal S; Singh P; Lipton RB
    J Headache Pain; 2020 Mar; 21(1):23. PubMed ID: 32122324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examination of unmet treatment needs among persons with episodic migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB; Buse DC; Serrano D; Holland S; Reed ML
    Headache; 2013 Sep; 53(8):1300-11. PubMed ID: 23879870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. United States Patients' Perspective of Living With Migraine: Country-Specific Results From the Global "My Migraine Voice" Survey.
    Gibbs SN; Shah S; Deshpande CG; Bensink ME; Broder MS; Dumas PK; Buse DC; Vo P; Schwedt TJ
    Headache; 2020 Jul; 60(7):1351-1364. PubMed ID: 32369201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensory Hypersensitivity Symptoms in Migraine With vs Without Aura: Results From the American Registry for Migraine Research.
    Pearl TA; Dumkrieger G; Chong CD; Dodick DW; Schwedt TJ
    Headache; 2020 Mar; 60(3):506-514. PubMed ID: 31965576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive population-based survey of migraine in Japan: results of the ObserVational Survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) study.
    Hirata K; Ueda K; Komori M; Zagar AJ; Selzler KJ; Nelson AM; Han Y; Jaffe DH; Matsumori Y; Takeshima T
    Curr Med Res Opin; 2021 Nov; 37(11):1945-1955. PubMed ID: 34429000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine.
    Silberstein SD; Lee L; Gandhi K; Fitzgerald T; Bell J; Cohen JM
    Headache; 2018 Nov; 58(10):1579-1592. PubMed ID: 30375650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The burden of headache disorders in Ethiopia: national estimates from a population-based door-to-door survey.
    Zebenigus M; Tekle-Haimanot R; Worku DK; Thomas H; Steiner TJ
    J Headache Pain; 2017 Dec; 18(1):58. PubMed ID: 28547735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and burden of headache in children and adolescents in Austria - a nationwide study in a representative sample of pupils aged 10-18 years.
    Philipp J; Zeiler M; Wöber C; Wagner G; Karwautz AFK; Steiner TJ; Wöber-Bingöl Ç
    J Headache Pain; 2019 Nov; 20(1):101. PubMed ID: 31694547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the classification of migraine subtypes: an empirical approach based on factor mixture models in the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB; Serrano D; Pavlovic JM; Manack AN; Reed ML; Turkel CC; Buse DC
    Headache; 2014 May; 54(5):830-49. PubMed ID: 24527745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive dysfunctions and psychological symptoms in migraine without aura: a cross-sectional study.
    Santangelo G; Russo A; Trojano L; Falco F; Marcuccio L; Siciliano M; Conte F; Garramone F; Tessitore A; Tedeschi G
    J Headache Pain; 2016 Dec; 17(1):76. PubMed ID: 27568039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventive treatment patterns and treatment satisfaction in migraine: results of the OVERCOME (EU) study.
    Pascual J; Panni T; Dell'Agnello G; Gonderten S; Novick D; Evers S
    J Headache Pain; 2023 Jul; 24(1):88. PubMed ID: 37460942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.